Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Apr 15, 2023; 15(4): 677-688
Published online Apr 15, 2023. doi: 10.4251/wjgo.v15.i4.677
Published online Apr 15, 2023. doi: 10.4251/wjgo.v15.i4.677
Figure 1 Kaplan-Meier estimates of disease-free survival (A) and overall survival (B) in patients with ampulla of Vater cancer according to the tumor, node, metastasis stage.
Figure 2 Kaplan-Meier curves for disease-free survival and overall survival by adjuvant chemotherapy.
A: The median disease-free survival was 17.2 mo in the adjuvant chemotherapy group, as compared with 13.0 mo in the surgery-alone group; B: The median overall survival was 43.3 mo in the adjuvant chemotherapy group, as compared with 55.0 mo in the surgery-alone group; C: The median disease-free survival; and D: Overall survival in patients with stage II-III disease according to adjuvant chemotherapy.
- Citation: Park SJ, Shin K, Kim IH, Hong TH, Kim Y, Lee MA. Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma. World J Gastrointest Oncol 2023; 15(4): 677-688
- URL: https://www.wjgnet.com/1948-5204/full/v15/i4/677.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i4.677